Hartmut Vatter

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

Richard E. Thompson, Michael Rosenblum, Gayane Yenokyan et al. · The Lancet · 2019 · 899 citations · Full text

Medicine, Neurosurgery, Surgery +15

Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial

Christian Senft, Andrea Bink, Kea Franz et al. · The Lancet Oncology · 2011 · 810 citations

Medicine, Neurosurgery, Surgery +14

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack et al. · The Lancet · 2019 · 576 citations · Full text

Medicine, Oncology, Pharmacology +16

Cranioplasty after Decompressive Craniectomy: The Effect of Timing on Postoperative Complications

Patrick Schuss, Hartmut Vatter, Gerhard Marquardt et al. · Journal of Neurotrauma · 2011 · 218 citations

Medicine, Neurosurgery, Surgery +13

Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age

Ági Oszvald, Erdem Güresir, Matthias Setzer et al. · Journal of neurosurgery · 2011 · 174 citations

Medicine, Oncology, Surgery +14